anti-ganglioside GM2 monoclonal antibody BIW-8962
Term · Oncology and biomedicine · MLC-T-ONC-010678
A humanized anti-ganglioside GM2 (GM2) monoclonal antibody with potential antineoplastic and immunomodulating activities. Upon administration, anti-ganglioside GM2 monoclonal antibody BIW-8962 may activate an antibody dependent cellular cytotoxicity (ADCC) against GM2-expressing tumor cells. GM2 is a tumor associated antigen (TAA) overexpressed on the surface of many cancer cells, such as multiple myeloma (MM) cells and neuroblastoma cells.
| Identifier | MLC-T-ONC-010678 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-GM2 monoclonal antibody BIW-8962 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010678",
"term": "anti-ganglioside GM2 monoclonal antibody BIW-8962",
"field": "Oncology and biomedicine",
"definition": "A humanized anti-ganglioside GM2 (GM2) monoclonal antibody with potential antineoplastic and immunomodulating activities. Upon administration, anti-ganglioside GM2 monoclonal antibody BIW-8962 may activate an antibody dependent cellular cytotoxicity (ADCC) against GM2-expressing tumor cells. GM2 is a tumor associated antigen (TAA) overexpressed on the surface of many cancer cells, such as multiple myeloma (MM) cells and neuroblastoma cells.",
"synonyms": [
"anti-GM2 monoclonal antibody BIW-8962"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-ganglioside-gm2-monoclonal-antibody-biw-8962/"
}
Record 1,781 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.